|
NOL7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.045700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.036690E-03 |
| Normal-vs-Stage2 |
1.107980E-01 |
| Normal-vs-Stage3 |
2.79609999997987E-06 |
| Normal-vs-Stage4 |
3.976200E-04 |
| Stage1-vs-Stage2 |
3.672000E-01 |
| Stage1-vs-Stage3 |
6.377600E-02 |
| Stage1-vs-Stage4 |
3.624000E-01 |
| Stage2-vs-Stage3 |
7.353900E-02 |
| Stage2-vs-Stage4 |
1.934010E-01 |
| Stage3-vs-Stage4 |
6.425000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.8971999999935E-05 |
| Normal-vs-AfricanAmerican |
2.277400E-01 |
| Normal-vs-Asian |
1.120310E-02 |
| Caucasian-vs-AfricanAmerican |
2.174400E-01 |
| Caucasian-vs-Asian |
2.942600E-01 |
| AfricanAmerican-vs-Asian |
7.106000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.76710000000014E-05 |
| Normal-vs-Female |
1.435240E-04 |
| Male-vs-Female |
4.300000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.217300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.214690E-04 |
| Normal-vs-Age(61-80Yrs) |
3.53130000000368E-05 |
| Normal-vs-Age(81-100Yrs) |
3.744100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.495000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.468100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.817400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.234000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.298000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.740600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.017900E-02 |
| Classical-VS-Follicular |
9.572600E-01 |
| Classical-VS-Other |
7.419000E-01 |
| Classical-VS-Normal |
3.197100E-04 |
| Tall-VS-Follicular |
8.244400E-02 |
| Tall-VS-Other |
1.752810E-01 |
| Tall-VS-Normal |
2.06239999999136E-05 |
| Follicular-VS-Other |
8.211000E-01 |
| Follicular-VS-Normal |
9.756800E-03 |
| Other-VS-Normal |
2.512600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.423400E-04 |
| Normal-vs-N1 |
5.552300E-04 |
| N0-vs-N1 |
5.854600E-01 |
|
|
